News
The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable biosimilar product referencing Novo Nordisk A/S’ Novolog (insulin aspart), a ...
New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new ...
The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.
A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...
3d
BabyCenter on MSNWhat to know about the RSV vaccine during pregnancyFind out whether you should get the RSV vaccine, known as Abrysvo, during pregnancy and when it's recommended.
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
Renta 4 | The FDA has given the green light to expand the use of Moderna’s vaccine for the treatment of RSV, the virus that causes bronchiolitis, in adults aged 18 to 59. This vaccine has already been ...
FDA accepts GSK's application to expand Arexvy vaccine use to at-risk adults aged 18–49, with a decision expected in the ...
As FDA kicked off the drug user fee reauthorization process, Commissioner Marty Makary said he’d like to see lower fees paid ...
The offering, the first IPO this year, attracted more than 32 billion dirhams ($3.5 bln) in demand for 500 million dirhams in shares. GSK seeks FDA nod for expanded use of RSV vaccine in adults ...
Public Health – Seattle and King County has seen an increase in emergency visits for COVID-19 over the last month, although the numbers are significantly lower than last year, as shown by data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results